10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 314 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,693,000 | -81.7% | 22,257 | -64.1% | 0.06% | -83.5% |
| Q4 2021 | $9,229,000 | -0.4% | 61,957 | -2.7% | 0.33% | +18.4% |
| Q3 2021 | $9,268,000 | -26.8% | 63,661 | -1.5% | 0.28% | -28.4% |
| Q2 2021 | $12,657,000 | -1.1% | 64,637 | -8.6% | 0.39% | +7.9% |
| Q1 2021 | $12,797,000 | +112.6% | 70,704 | +66.4% | 0.36% | +66.7% |
| Q4 2020 | $6,018,000 | -35.4% | 42,500 | -43.1% | 0.22% | -54.4% |
| Q3 2020 | $9,316,000 | +137.5% | 74,720 | +70.1% | 0.48% | +27.3% |
| Q2 2020 | $3,923,000 | +15.2% | 43,920 | -19.6% | 0.38% | -6.7% |
| Q1 2020 | $3,404,000 | -48.9% | 54,620 | -37.5% | 0.40% | -31.1% |
| Q4 2019 | $6,660,000 | +46.8% | 87,340 | -3.0% | 0.59% | -24.4% |
| Q3 2019 | $4,536,000 | – | 90,000 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |